Term Name:	beta-D-ManpA4Ac-(1->3)-alpha-L-FucpNAc-(1->3)-alpha-D-FucpNAcO[CH2]3NH2
Synonyms:	3-aminopropyl 2-acetamido-4-O-acetyl-2-deoxy-beta-D-mannopyranuronosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-L-galactopyranosyl-(1->3)-2-acetamido-2,6-dideoxy-alpha-D-galactopyranoside, 3-aminopropyl 3-O-(3-O-[4-O-acetyl-2-acetamido-2-deoxy-beta-D-mannopyranosyluronic acid]-2-acetamido-2-deoxy-alpha-L-fucopyranosyl)-2-acetamido-2-deoxy-alpha-D-fucopyranoside, 3-aminopropyl N-acetyl-4-O-acetyl-beta-D-mannuronosaminyl-(1->3)-N-acetyl-alpha-L-galactosaminyl-(1->3)-N-acetyl-alpha-D-galactosaminide, beta-D-ManA4Ac-(1->3)-alpha-L-FucNAc-(1->3)-alpha-D-FucNAc-O[CH2]3NH2, ManA4Acbeta1-3FucNAcalpha1-3DFucNAcalpha-O[CH2]3NH2
Definition:	A linear trisaccharide derivative consisting of 2-acetamido-4-O-acetyl-2-deoxy-beta-D-mannuronic acid, N-acetyl-alpha-L-fucosamine and N-acetyl-alpha-D-fucosamine residues all linked sequentially (1->3) with the N-acetylfucosamine residue linked glycosidically to a 3-aminopropyl group. A synthetic conjugation-ready CP8 trisaccharide bearing an amine linker, which effectively serves for immunological evaluation in Staphylococcus aureus vaccine development.
Ontology:	ChEBI [CHEBI:155894]  ( EBI )